{
  "id": 18302777,
  "title": "STAT+: A closer look at ProMis Neurosciences and its Alzheimer’s drug",
  "url": "https://urgent.news/2026/11/05/stat-a-closer-look-at-promis-neurosciences-and-its-alzheimers-drug",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-05T11:30:00.000Z",
  "source": {
    "name": "STAT News",
    "slug": "stat-news",
    "url": "https://www.statnews.com/2026/11/05/promis-neurosciences-alzheimers-disease-acumen-vertex-kidney-drug/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Shares of ProMis Neurosciences, developer of a treatment for Alzheimer’s disease, sold off sharply last week. A closer look at the reason why — and whether it holds up.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}